West Virginia Medicaid

Does West Virginia Medicaid cover Zepbound?

Quick answer · Weight Loss

West Virginia Medicaid does not cover it for weight loss on Medicaid.

  • Medicaid: Not covered. Agents used for the purpose of weight loss are typically a benefit exclusion and not covered by West Virginia Medicaid. Coverage of Zepbound will only be considered for a diagnosis of OSA in adults with obesity.

Last verified June 3, 2026. Policy effective July 1, 2025. Source: download. How we verify this data →

Check your card for your exact plan →

Zepbound for Weight Loss

What West Virginia Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Not covered

Agents used for the purpose of weight loss are typically a benefit exclusion and not covered by West Virginia Medicaid. Coverage of Zepbound will only be considered for a diagnosis of OSA in adults with obesity.

Policy note: West Virginia Medicaid explicitly excludes weight loss as a covered indication for Zepbound. Coverage is only considered for OSA in adults with obesity.

Policy effective July 1, 2025 · verified June 3, 2026 · source: download

Zepbound for Osa

What West Virginia Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • Age 18 and older
  • BMI of 30 or higher
  • Diagnosed obstructive sleep apnea (AHI of 15 or higher)

Qualification pathways

You can qualify through any one of these.

Initial Approval — OSA in Adults with Obesity (No Concurrent T2DM)

All of:

  • Patient is within the FDA-labeled age range (adults)
  • Diagnosis of moderate to severe OSA confirmed by sleep study within the past 12 months with AHI >= 15 events/hour
  • Diagnosis of obesity with documented BMI >= 30 kg/m² within the past 3 months (date and BMI result stated on request)
  • Patient has been prescribed or counseled on use of CPAP as a potential therapy
  • Patient has received counseling on chronic weight management (increased physical activity and reduced calorie diet) and will continue ongoing counseling during treatment
  • Patient is not receiving Zepbound in combination with other tirzepatide-containing products or any other GIP/GLP-1 class agents

Initial Approval — OSA in Adults with Obesity and Concurrent Type II Diabetes

All of:

  • Patient is within the FDA-labeled age range (adults)
  • Diagnosis of moderate to severe OSA confirmed by sleep study within the past 12 months with AHI >= 15 events/hour
  • Diagnosis of obesity with documented BMI >= 30 kg/m² within the past 3 months (date and BMI result stated on request)
  • Patient has been prescribed or counseled on use of CPAP as a potential therapy
  • Patient has received counseling on chronic weight management (increased physical activity and reduced calorie diet) and will continue ongoing counseling during treatment
  • Patient has concurrent diagnosis of Type II Diabetes Mellitus and has been trialed on a preferred GLP-1 (indicated for Type II DM) compliantly for three months with treatment failure
  • Patient is not receiving Zepbound in combination with other tirzepatide-containing products or any other GIP/GLP-1 class agents

Documentation to bring

  • Sleep study results within the past 12 months confirming AHI >= 15 events/hour
  • Documented BMI >= 30 kg/m² with date and results of most recent weight and BMI calculation within the past 3 months
  • Documentation of prescription or counseling on CPAP as a potential therapy
  • Documentation of counseling on chronic weight management (increased physical activity and reduced calorie diet)
  • If concurrent Type II Diabetes diagnosis: documentation of compliant 3-month trial of a preferred GLP-1 (indicated for Type II DM) and treatment failure
  • Attestation that patient is not receiving Zepbound in combination with other tirzepatide-containing products or other GIP/GLP-1 class agents

Quantity limits

  • all strengths — 30-day supply

Approval and renewal

  • Renewal: every 6 months
  • To renew, the plan looks for at least 5% weight loss from the starting weight, Clinical improvement of OSA while on Zepbound (e.g., patient-reported improvement in daytime sleepiness, partner-reported reduction of snoring/pauses in breathing, reduction of AHI events). Patient must also tolerate at least 10 mg maintenance dose, demonstrate documented compliance, and continue reduced calorie diet and increased physical activity. Initial BMI, OSA diagnosis, and GLP-1 step-therapy requirements are not explicitly re-verified at continuation, and staying on a maintenance dose of at least 10 mg. Make sure your starting weight and date are in the chart now — renewal is measured against it.

Not covered when

  • Concurrent use with other tirzepatide-containing products
  • Concurrent use with other GIP/GLP-1 class agents
  • Patients with concurrent Type II Diabetes who have not failed a 3-month compliant trial of a preferred GLP-1 indicated for Type II DM

Policy note: Initial approvals may be authorized for 150 days. Further approvals may be granted for 6 months after all continuation criteria are met. All fills are limited to a 30-day supply. OSA confirmation requires AHI >= 15 events/hour (moderate to severe). CPAP must be prescribed or counseled — a full prior trial/failure is not required. Patients with concurrent T2DM must have tried a preferred GLP-1 (for T2DM) for 3 months with failure before Zepbound is approved. Reauthorization requires: documented compliance, tolerance of at least 10 mg maintenance dose, continued diet/activity plan adherence, clinical improvement of OSA, AND documented weight loss >5% or maintenance of initial 5% weight loss.

Policy effective July 1, 2025 · verified June 3, 2026 · source: download

Why Zepbound requests get denied by West Virginia Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Your plan's benefit excludes weight loss medications. A prior authorization cannot override a benefit exclusion — ask about a formulary exception or a different covered pathway.
  2. Wrong brand for the diagnosis. Zepbound and Mounjaro are the same molecule with different approved uses; a request for Zepbound under a diagnosis that matches Mounjaro is routinely denied.
  3. BMI not documented in the chart notes (or documented without a baseline weight and date).
  4. Baseline weight wasn't recorded at the start, so the required weight loss can't be shown at renewal.

If weight loss isn't covered on your plan

West Virginia Medicaid has separate Zepbound policies that don't depend on the weight loss benefit:

  • Osa — covered on Medicaid.

Zepbound is also sold directly by Eli Lilly without insurance through LillyDirect.

Frequently asked questions

Does West Virginia Medicaid cover Zepbound?
West Virginia Medicaid does not cover it for weight loss on Medicaid.
What does West Virginia Medicaid require to renew Zepbound?
At least 5% weight loss from the starting weight, Clinical improvement of OSA while on Zepbound (e.g., patient-reported improvement in daytime sleepiness, partner-reported reduction of snoring/pauses in breathing, reduction of AHI events). Patient must also tolerate at least 10 mg maintenance dose, demonstrate documented compliance, and continue reduced calorie diet and increased physical activity. Initial BMI, OSA diagnosis, and GLP-1 step-therapy requirements are not explicitly re-verified at continuation, and staying on a maintenance dose of at least 10 mg.
What if my plan excludes weight loss medications?
West Virginia Medicaid has separate Zepbound policies for osa, which are covered on some plan types and don't depend on the weight-loss benefit. Zepbound is also available for cash through LillyDirect.
How current is this information?
This page reflects West Virginia Medicaid's written policy as of July 1, 2025, last verified against the source document on June 3, 2026.

Other medications under West Virginia Medicaid

Zepbound coverage under other plans

All insurance plans · All medications

This page summarizes West Virginia Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.